A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA
A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA
Active, not recruiting · NCT05601232 · Registry updated 2025-04-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA | Unresectable Angiosarcoma | Active, not recruiting | Phase 2 | 2025-04-09 | NCT05601232 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cancer Intelligence Care Systems, Inc. | 2 |
| Stella Pharma Corporation | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Cancer Center Hospital | Tokyo | Japan | 20 |